Knowles Corporation (KN) Stock Price & How to Invest

Knowles Corporation designs and manufactures specialized electronic components that perform critical, hard-to-replicate functions in demanding devices. It operates in two segments: Precision Devices (PD), which makes high-performance capacitors and radio-frequency and microwave filters for defense, medtech, industrial, and electrification markets, and MedTech & Specialty Audio (MSA), which makes balanced armature speakers, hearing-aid microphones, and specialty audio parts. After selling its lower-margin consumer MEMS microphone business, Knowles now positions itself as a focused supplier of differentiated, high-reliability components rather than a volume consumer-electronics vendor.

The investment picture centers on that transformation. Full-year 2025 revenue reached about $593 million with adjusted EBIT of roughly $120 million, and Q1 2026 revenue grew about 16 percent year over year to roughly $153 million with both segments expanding. The bull case is a steadier, higher-margin business tied to defense and medical demand that generates consistent free cash flow used for buybacks and acquisitions. The bear case is that KN remains a small-cap industrial supplier exposed to cyclical end markets, customer concentration, and the execution risk of integrating deals, so its premium multiple leaves little room for a stumble.

Knowles is a small-cap supplier exposed to cyclical industrial, electrification, and defense budget swings, and a slowdown in any large end market could pressure results. Customer and end-market concentration means a few large programs matter to the numbers. Acquisitions carry integration and valuation risk, and the shares trade at a premium that leaves limited margin for execution misses. Tariffs, supply-chain costs, and foreign-exchange movements can also weigh on margins given global manufacturing. Finally, competition from larger passive-component and audio suppliers could compress pricing over time.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Knowles Corporation's investor relations page or your broker.

• Revenue (TTM): ~$610M
• FY2025 revenue: ~$593M
• Adjusted EBIT (FY2025): ~$120M
• Adjusted free cash flow (FY2025): ~$114M
• Market cap: ~$3.1B
• Share price: ~$35

Revenue grew about 7 percent in 2025 and accelerated to roughly 16 percent year over year in Q1 2026, with non-GAAP EPS up about 50 percent that quarter. The stock trades near the upper end of its 52-week range (about $17 to $43), so the market is pricing in continued margin and cash-flow improvement. These are approximate figures drawn from recent filings and financial data providers.

There are three common ways to get KN exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic basket, so KN sits alongside other stocks that express the same thesis.

Walnut takes the basket route. Describe a thesis where KN fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

KN is a small-cap industrial component supplier whose value hinges on whether its precision-devices and medtech mix keeps compounding margins and free cash flow.

Whether KN is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is KN a buy?, and where the stock could go from here in the KN stock forecast.

For income investors, whether KN pays a dividend and how the payout looks is covered in does KN pay a dividend?